PEAK Surgical's plasma electrosurgical tools net $21M

peak-surgical-logo-200px.gifPalo Alto, Calif.-based PEAK Surgical, a device company developing new surgical tools that aim to control bleeding via electric energy, raised $21 million in a third funding round. Investors included Signet Healthcare Partners, Lehman Brothers and Venrock Associates.

The company is working on new electrosurgical tools that it says should offer significant improvements over the existing technology for using electric pulses to heat surgical instruments for cutting or coagulation of tissue. PEAK doesn’t go into great detail about its technique on its Web site or in its release, except to cite a number of scientific references and to say that it relies on short-pulsed, “plasma-mediated” electrical discharges.

The technology, however, originated at Stanford, where PEAK, it turns out, stands for “pulsed electron-avalanche knife.” The technique, developed by a team led by Daniel Palanker, involves using a high voltage electric field to create a plasma, a kind of electrically charged gas, which can be shaped and controlled to make clean cuts in tissue.

PEAK — the company, that is — claims the technology can limit the heat damage that normal electrosurgical tools can cause to surrounding tissue. Although the technique seems to have originated for use in retinal surgery, PEAK says that it is exploring its use in almost every surgical field but ophthalmic, including general, heart, gynecologic, plastic and neurological surgery.

Next Story:
Previous Story:

Tags: , , ,

Photo of David P. Hamilton

About the Author,

David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.

blog comments powered by Disqus